N Engl J Med 2017; 376:1178-1181March 23, 2017http://doi.org/10.1056/NEJMsb1702054
"A substantial body of readily available data from clinical trials can be shared with minimal risk to patients or researchers. Examples include data sets of already published trials, particularly if the treatments that were tested are not undergoing review for regulatory approval."
No comments:
Post a Comment